Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Number of holders
-
440
-
Total 13F shares, excl. options
-
22,717,723
-
Shares change
-
-1,836,356
-
Total reported value, excl. options
-
$1,389,309,843
-
Value change
-
-$126,515,786
-
Put/Call ratio
-
288%
-
Number of buys
-
145
-
Number of sells
-
-292
-
Price
-
$61.24
Significant Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2021
571 filings reported holding ARKG - ARK ETF TR - GENOMIC REV ETF as of Q4 2021.
ARK ETF TR - GENOMIC REV ETF (ARKG) has 440 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,717,723 shares
.
Largest 10 shareholders include MORGAN STANLEY (3,632,377 shares), BANK OF AMERICA CORP /DE/ (1,632,450 shares), UBS Group AG (1,327,024 shares), LPL Financial LLC (1,127,061 shares), WELLS FARGO & COMPANY/MN (1,089,813 shares), Eversept Partners, LP (664,484 shares), GOLDMAN SACHS GROUP INC (662,233 shares), BNP PARIBAS ARBITRAGE, SA (641,463 shares), COMMONWEALTH EQUITY SERVICES, LLC (593,764 shares), and JANE STREET GROUP, LLC (478,046 shares).
This table shows the top 440 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.